Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) France

Research

Date range: 1 September 2020 - 31 August 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)
Count Share
2 0.32

Outputs by subject (Share)

Outputs by subject
Subject Count Share
2 0.32

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.94 1.48 0.53 0.56 0.39

Compare Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) with other institutions

Collaboration

Date range: 1 September 2020 - 31 August 2021

International vs. domestic collaboration by Share

  • 37.67% Domestic
  • 62.33% International

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) by Share (9 total)

  1. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and National Institute for Health and Medical Research (INSERM) (0.45)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.32
    0.13
  2. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and University of Évry-Val d'Essonne (UEVE) (0.44)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.32
    0.12
  3. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and École Pratique des Hautes Études (EPHE) (0.40)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.32
    0.08
  4. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and Genethon (0.40)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.32
    0.08
  5. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and Institute of Myology (0.07)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.04
  6. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and Sorbonne University (0.04)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.01
  7. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and The French Alternative Energies and Atomic Energy Commission (CEA) (0.04)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.01
  8. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.04)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.01
  9. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and French National Centre for Scientific Research (CNRS) (0.04)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.01

Top 10 international collaborators with Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) by Share (23 total)

  1. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and Children's National Health System (0.93)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.29
    0.64
  2. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and Harvard University (0.37)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.34
  3. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and The George Washington University (GW) (0.36)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.29
    0.07
  4. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and Hansjorg Wyss Institute for Biologically Inspired Engineering (0.24)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.20
  5. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and University of Louisville (UofL) (0.17)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.13
  6. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and University of Massachusetts Medical School (UMass Medical School) (0.15)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.11
  7. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and Charles River Laboratories, Inc. (0.13)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.10
  8. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and Ally Therapeutics Inc. (0.12)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.08
  9. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and University of Bristol (UoB) (0.09)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.06
  10. Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE) and Boston University (BU) (0.05)
    Integrated Genetic Approaches in Therapeutic Discovery for Rare Diseases (INTEGRARE)0.04
    0.02

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.